SIR and excess number of second cancer in the male population (1320 patients)
Second cancer . | No. observed . | SIR . | 95% CI . | P . | Excess numbers . |
|---|---|---|---|---|---|
| All types | 44 | 0.92 | 0.67-1.24 | .73 | — |
| Solid tumors | 35 | 0.77 | 0.54-1.07 | .95 | — |
| Lung | 19 | 2.45 | 1.48-3.83 | < .001 | 19.9 |
| Head and neck | 2 | 0.38 | 0.005-1.37 | .97 | — |
| Digestive | 5 | 0.52 | 0.17-1.12 | .96 | — |
| AML/MDS | 4 | 5.65 | 1.54-14.46 | .006 | 5.8 |
Second cancer . | No. observed . | SIR . | 95% CI . | P . | Excess numbers . |
|---|---|---|---|---|---|
| All types | 44 | 0.92 | 0.67-1.24 | .73 | — |
| Solid tumors | 35 | 0.77 | 0.54-1.07 | .95 | — |
| Lung | 19 | 2.45 | 1.48-3.83 | < .001 | 19.9 |
| Head and neck | 2 | 0.38 | 0.005-1.37 | .97 | — |
| Digestive | 5 | 0.52 | 0.17-1.12 | .96 | — |
| AML/MDS | 4 | 5.65 | 1.54-14.46 | .006 | 5.8 |
— indicates not applicable.